Successful completion of development of a precision therapeutic system designed to safely achieve high concentration…
![](https://focalmedical.co/wp-content/uploads/2020/10/iStock-1227586908.jpeg)
PRESS RELEASE: Advanced Chemotherapy Technologies, Inc. Announces $5.5M Series A Financing Round led by Khosla Ventures
The capital will be used to fund initial clinical development of the company’s ACT-IOP-003 local chemotherapy system for the treatment of locally advanced non-resectable and borderline resectable pancreatic cancer.